Literature DB >> 20425523

Theories of the pathogenesis of inclusion body myositis.

Steven A Greenberg1.   

Abstract

Inclusion body myositis is a progressive disease of the skeletal muscle. Here, specific theories of its pathogenesis are reviewed and general considerations pertaining to modeling of this disease discussed. Understanding of inclusion body myositis disease mechanism remains extremely poor. Current published animal models do not represent the disease. Future studies need to consider the critical role of biomarkers and methodologic issues in their discovery.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20425523      PMCID： PMC2929917          DOI： 10.1007/s11926-010-0102-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.686


  49 in total

1.  Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis.

Authors:  C C Yang; R B Alvarez; W K Engel; V Askanas
Journal:  Neuroreport       Date:  1996-12-20       Impact factor: 1.837

Review 2.  Pathology of the inflammatory myopathies.

Authors:  G Karpati; S Carpenter
Journal:  Baillieres Clin Neurol       Date:  1993-11

3.  Nature of "Tau" immunoreactivity in normal myonuclei and inclusion body myositis.

Authors:  Mohammad Salajegheh; Jack L Pinkus; Remedios Nazareno; Anthony A Amato; Kenneth C Parker; Steven A Greenberg
Journal:  Muscle Nerve       Date:  2009-10       Impact factor: 3.217

4.  Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications.

Authors:  Steven A Greenberg
Journal:  Neurology       Date:  2007-10-10       Impact factor: 9.910

5.  Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis.

Authors:  Xuesong Chen; Othman Ghribi; Jonathan D Geiger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-01-23       Impact factor: 3.619

6.  TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia.

Authors:  C C Weihl; P Temiz; S E Miller; G Watts; C Smith; M Forman; P I Hanson; V Kimonis; A Pestronk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10       Impact factor: 10.154

7.  Myxovirus-like structures in a case of human chronic polymyositis.

Authors:  S M Chou
Journal:  Science       Date:  1967-12-15       Impact factor: 47.728

8.  Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta.

Authors:  Masashi Kitazawa; Dan N Trinh; Frank M LaFerla
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

9.  Human muscle macrophages express beta-amyloid precursor and prion proteins and their mRNAs.

Authors:  V Askanas; E Sarkozi; M Bilak; R B Alvarez; W K Engel
Journal:  Neuroreport       Date:  1995-05-09       Impact factor: 1.837

10.  The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis.

Authors:  Agnès Delaunay; Kenneth D Bromberg; Yukiko Hayashi; Massimiliano Mirabella; Denise Burch; Brian Kirkwood; Carlo Serra; May C Malicdan; Andrew P Mizisin; Roberta Morosetti; Aldobrando Broccolini; Ling T Guo; Stephen N Jones; Sergio A Lira; Pier Lorenzo Puri; G Diane Shelton; Ze'ev Ronai
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240
View more
  19 in total

1.  Sporadic inclusion body myositis: new insights and potential therapy.

Authors:  Pedro M Machado; Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Opin Neurol       Date:  2014-10       Impact factor: 5.710

Review 2.  A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review.

Authors:  A M Clerici; G Bono; M L Delodovici; G Azan; G Cafasso; G Micieli
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 3.  Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.

Authors:  Andrew L Mammen
Journal:  Nat Rev Neurol       Date:  2011-06-08       Impact factor: 42.937

Review 4.  Novel therapeutic approaches for inclusion body myositis.

Authors:  Thomas E Lloyd
Journal:  Curr Opin Rheumatol       Date:  2010-11       Impact factor: 5.006

Review 5.  Expression and function of APP and its metabolites outside the central nervous system.

Authors:  Kendra L Puig; Colin K Combs
Journal:  Exp Gerontol       Date:  2012-07-27       Impact factor: 4.032

6.  Targeting protein homeostasis in sporadic inclusion body myositis.

Authors:  Mhoriam Ahmed; Pedro M Machado; Adrian Miller; Charlotte Spicer; Laura Herbelin; Jianghua He; Janelle Noel; Yunxia Wang; April L McVey; Mamatha Pasnoor; Philip Gallagher; Jeffrey Statland; Ching-Hua Lu; Bernadett Kalmar; Stefen Brady; Huma Sethi; George Samandouras; Matt Parton; Janice L Holton; Anne Weston; Lucy Collinson; J Paul Taylor; Giampietro Schiavo; Michael G Hanna; Richard J Barohn; Mazen M Dimachkie; Linda Greensmith
Journal:  Sci Transl Med       Date:  2016-03-23       Impact factor: 17.956

7.  [New aspects on the pathogenesis of myositis].

Authors:  B Stuhlmüller; E Feist; T Häupl; G-R Burmester; N Pipitone
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

Review 8.  Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2011-01-21       Impact factor: 6.682

9.  Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis.

Authors:  Kyla A Britson; Jonathan P Ling; Kerstin E Braunstein; Janelle M Montagne; Jenna M Kastenschmidt; Andrew Wilson; Chiseko Ikenaga; William Tsao; Iago Pinal-Fernandez; Katelyn A Russell; Nicole Reed; Tahseen Mozaffar; Kathryn R Wagner; Lyle W Ostrow; Andrea M Corse; Andrew L Mammen; S Armando Villalta; H Benjamin Larman; Philip C Wong; Thomas E Lloyd
Journal:  Sci Transl Med       Date:  2022-01-19       Impact factor: 19.319

10.  Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis.

Authors:  Arundhati Ray; Anthony A Amato; Elizabeth M Bradshaw; Kevin J Felice; Daniel B DiCapua; Jonathan M Goldstein; Ingrid E Lundberg; Richard J Nowak; Hidde L Ploegh; Eric Spooner; Qian Wu; Simon N Willis; Kevin C O'Connor
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.